Effect of Aprotinin on Transfusion Requirements and Blood Loss in Patients Undergoing Elective Primary Total Hip Replacement
Public ClinicalTrials.gov record NCT00668031. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Design, 2-Arm Study to Investigate the Effect of Aprotinin on Transfusion Requirements and Blood Loss in Patients Undergoing Elective Primary Total Hip Replacement Surgery
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess if aprotinin (BAY A0128), given intravenously during surgery, is safe and can help reduce the amount of bleeding and the need for a blood transfusion during hip replacement surgery. Patients undergoing major surgery are at risk for significant blood loss. Because of this, there is a need for drugs that will help slow the amount of bleeding during surgery.
Study identification
- NCT ID
- NCT00668031
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 359 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2005 (Type not available)
- Primary completion
- Jan 2006 (Actual)
- Completion
- Jan 2006 (Actual)
- Last update posted
- Dec 30, 2014
2005 – 2006
United States locations
- U.S. sites
- 27
- U.S. states
- 16
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35205 | — |
| Not listed | Mobile | Alabama | 36608 | — |
| Not listed | Phoenix | Arizona | 85023 | — |
| Not listed | La Jolla | California | 92037 | — |
| Not listed | San Diego | California | 92123 | — |
| Not listed | Aurora | Colorado | 80012 | — |
| Not listed | Farmington | Connecticut | 06032 | — |
| Not listed | Bay Pines | Florida | 33744 | — |
| Not listed | Jacksonville Beach | Florida | 32250 | — |
| Not listed | Sarasota | Florida | 34239 | — |
| Not listed | St. Petersburg | Florida | 33703 | — |
| Not listed | Boise | Idaho | 83702 | — |
| Not listed | Indianapolis | Indiana | 46260 | — |
| Not listed | Mooresville | Indiana | 46158 | — |
| Not listed | Iowa City | Iowa | 52242-1089 | — |
| Not listed | Baltimore | Maryland | 21215 | — |
| Not listed | Worcester | Massachusetts | 01655 | — |
| Not listed | Kalamazoo | Michigan | 49009 | — |
| Not listed | Ypsilanti | Michigan | 48197 | — |
| Not listed | Durham | North Carolina | 27710 | — |
| Not listed | Greensboro | North Carolina | 27401 | — |
| Not listed | Bend | Oregon | 97701 | — |
| Not listed | Philadelphia | Pennsylvania | 19107 | — |
| Not listed | Pittsburgh | Pennsylvania | 15213-2592 | — |
| Not listed | Dallas | Texas | 75231 | — |
| Not listed | Lubbock | Texas | 79410 | — |
| Not listed | San Antonio | Texas | 78233 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00668031, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 30, 2014 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00668031 live on ClinicalTrials.gov.